

Arthi Sridhar
1.2K posts

@ASridharMD
Thoracic Oncologist @UTSWHemeOnc | Training @MayoCancerCare, @McGovernHemeOnc| #LCSM #globaloncology #patienteducation #meded| @ASCOTECAG | Tweets are mine






In a phase 1 study of the oral p53 reactivator rezatapopt in heavily pretreated patients with TP53 Y220C–mutated solid tumors, the most common adverse events were nausea and vomiting, and the overall response was 20%. Full PYNNACLE study results: nej.md/3OIQC5P Science behind the Study: Restoring Function to a Variant of p53 in Solid Tumors nej.md/3N0pQW8


























(3/3) Meet the 2026 HOPE Ambassadors, a group of veteran attendees that will be there every step of the way to ask questions, make connections, and greet you with a smile when you arrive on May 1st! Register now: lungevity.org/hopesummit

⭐️Physicians Are Not Providers: The Ethical Significance of Names in Health Care: A Policy Paper From the American College of Physicians | Annals of Internal Medicine acpjournals.org/doi/10.7326/AN…






👩⚕️🩺❤️ We salute all women physicians who continue to inspire and shatter barriers in health care. May you feel appreciated today and always @ShikhaJainMD @fumikochino @stolaney1 @NarjustFlorezMD @reshmajagsi @AnnPartridgeMD @drteplinsky @DrAmyComander bit.ly/4bRYTOH
